Core Viewpoint - Optimi Health Corp. has initiated an underwritten public offering of its common shares in the United States as part of its strategy to list on the Nasdaq Capital Market [1][2] Group 1: Offering Details - The offering will be managed by Joseph Gunnar & Co., LLC, and the company has applied to list its shares on Nasdaq under the symbol "OPTH" [2] - The offering is subject to market conditions and the completion of the SEC and Nasdaq review process, with no assurance on the timing or terms of completion [4][16] - The offering will be conducted under a prospectus as part of an effective registration statement filed with the SEC [3] Group 2: Share Consolidation - The company's board has approved a consolidation of its outstanding shares at a ratio of one post-consolidation share for every thirty pre-consolidation shares [7] - This consolidation aims to meet Nasdaq's minimum share price requirement and will not affect shareholders' proportionate ownership, except for fractional shares [8][9] - Following the consolidation, the company expects to have approximately 3,225,897 shares outstanding [9] Group 3: Company Overview - Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies [12] - The company produces validated MDMA and botanical psilocybin drug products at its GMP-compliant facilities in British Columbia, Canada [12] - Optimi supplies both active pharmaceutical ingredients and finished dosage forms to regulated clinical and therapeutic programs internationally [13]

Core Viewpoint - RYVYL's largest shareholder, Roundtable, has increased its investment to $6.5 million and supported key proposals to ensure compliance with Nasdaq ahead of a merger [1][4] Shareholder Voting Outcomes - Over 90% of shareholder voters agreed to increase the share price to maintain Nasdaq listing, which is deemed critical for shareholder value and the merger [2] - Shareholders approved a reverse stock split of the Company's outstanding common stock at a ratio between 1-for-20 and 1-for-50 shares [2][3] - The exact ratio for the reverse stock split will be determined by RYVYL's board based on market conditions and shareholder analysis [3] Authorized Share Increase - Shareholders approved an increase in the number of authorized shares from 100,000,000 to 500,000,000 [3]

CoinShares has withdrawn its SEC filings for planned $XRP, $SOL staking, and $LTC ETFs.The firm is shifting focus as it pursues a Nasdaq listing through a $1.2B merger, aiming to become a publicly traded company.Source: Crypto Briefing ...

RT Cointelegraph (@Cointelegraph)🚨 LATEST: SOL Strategies has become the first Solana treasury company to receive approval for a Nasdaq listing. https://t.co/VfC7NelWPr ...